These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1417423

  • 1. [Experimental model of Parkinson disease: mechanisms and anatomo- pathological characteristics of MPTP neurotoxicity].
    Herrero MT, Luquín MR, Obeso JA.
    Arch Neurobiol (Madr); 1992; 55(4):175-82. PubMed ID: 1417423
    [Abstract] [Full Text] [Related]

  • 2. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
    Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage JM.
    Neurologia; 1991 Oct; 6(8):287-94. PubMed ID: 1790005
    [Abstract] [Full Text] [Related]

  • 3. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Nature; 1991 Oct; 327(6120):324-6. PubMed ID: 2884568
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Oct; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 10. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
    Chiueh CC, Miyake H, Peng MT.
    Adv Neurol; 1993 Oct; 60():251-8. PubMed ID: 8380519
    [No Abstract] [Full Text] [Related]

  • 11. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N, Bergh JJ, Petzer JP.
    Life Sci; 2007 Jul 19; 81(6):458-67. PubMed ID: 17655878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS, Bankiewicz KS, Quarantelli M, Plunkett RJ, Frank J, Kopin IJ, Di Chiro G.
    Ann Neurol; 1994 Jun 19; 35(6):689-97. PubMed ID: 8210225
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas.
    Singer TP, Ramsay RR, Sonsalla PK, Nicklas WJ, Heikkila RE.
    Adv Neurol; 1993 Jun 19; 60():300-5. PubMed ID: 8380523
    [No Abstract] [Full Text] [Related]

  • 17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 18. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI, Riachi NJ, Hritz MA, Berridge MS, Sayre LM.
    J Pharmacol Exp Ther; 1993 Aug 19; 266(2):790-5. PubMed ID: 8355208
    [Abstract] [Full Text] [Related]

  • 19. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M, Kettler R, Keller HH, Bonetti EP, Imhof R.
    Adv Neurol; 1987 Aug 19; 45():175-8. PubMed ID: 2881442
    [No Abstract] [Full Text] [Related]

  • 20. Neuropharmacological manipulations with MPTP.
    Barnes NJ, Bradbury AJ, Costall B, Domeney AM, Kelly ME, Naylor RJ.
    J Neural Transm Suppl; 1986 Aug 19; 20():47-63. PubMed ID: 3091761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.